BIOMAT Database Logo BIOMAT Database Logo

Antibody avidity measurement and immune complex dissociation for serological diagnosis of vertically acquired HIV-1 infection. 1993

F Simon, and C Rahimy, and A Krivine, and M Levine, and J M Pepin, and D Lapierre, and E Denamur, and L Vernoux, and A De Crepy, and P Blot
Laboratoire de Virologie, Hôpital Bichat-Cl. Bernard, Paris, France.

Differences in avidity between HIV-1 antibodies transmitted passively and antibodies synthesized by children born to HIV-1-positive mothers can be measured using a commercially available competitive enzyme immunoassay kit. The avidity determination method is based on the competition between an anti-HIV-1-peroxidase-labeled antibody at a stable and known concentration and the anti-HIV-1 antibodies (IgA, IgG, IgM) present in the child's serum at various and increasing dilutions. The shift in the competition/dilution curves between serum samples taken at the third and the sixth month of the child's life showed either the loss or the synthesis of anti-HIV-1 antibodies. The antibody avidity determination combined with a test detecting free or complexed p24 antigen is a workable and inexpensive serological method for the follow-up of children born to seropositive mothers. Combining these two complementary methods, HIV-1 infection has been established at 6 months of age in 13 of 13 infants, and positive results were confirmed by coculture and by PCR. An HIV-1 infection was excluded at 6 months of age in 17 of 17 infants, results otherwise confirmed by virological and clinical follow-up. These new and convenient approaches to the diagnosis of vertically acquired HIV-1 could be used worldwide, including in developing countries.

UI MeSH Term Description Entries
D007112 Immunity, Maternally-Acquired Resistance to a disease-causing agent induced by the introduction of maternal immunity into the fetus by transplacental transfer or into the neonate through colostrum and milk. Fetal Immunity, Maternally-Acquired,Maternally-Acquired Immunity,Neonatal Immunity, Maternally-Acquired,Immunity, Maternally Acquired,Fetal Immunities, Maternally-Acquired,Fetal Immunity, Maternally Acquired,Immunity, Maternally-Acquired Fetal,Immunity, Maternally-Acquired Neonatal,Maternally Acquired Immunities,Maternally Acquired Immunity,Maternally-Acquired Fetal Immunities,Maternally-Acquired Fetal Immunity,Maternally-Acquired Immunities,Maternally-Acquired Neonatal Immunities,Maternally-Acquired Neonatal Immunity,Neonatal Immunities, Maternally-Acquired,Neonatal Immunity, Maternally Acquired
D007124 Immunoenzyme Techniques Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens. Antibody Enzyme Technique, Unlabeled,Enzyme Immunoassay,Enzyme-Labeled Antibody Technique,Immunoassay, Enzyme,Immunoperoxidase Techniques,Peroxidase-Antiperoxidase Complex Technique,Peroxidase-Labeled Antibody Technique,Antibody Enzyme Technic, Unlabeled,Enzyme-Labeled Antibody Technic,Immunoenzyme Technics,Immunoperoxidase Technics,Peroxidase-Antiperoxidase Complex Technic,Peroxidase-Labeled Antibody Technic,Antibody Technic, Enzyme-Labeled,Antibody Technic, Peroxidase-Labeled,Antibody Technics, Enzyme-Labeled,Antibody Technics, Peroxidase-Labeled,Antibody Technique, Enzyme-Labeled,Antibody Technique, Peroxidase-Labeled,Antibody Techniques, Enzyme-Labeled,Antibody Techniques, Peroxidase-Labeled,Enzyme Immunoassays,Enzyme Labeled Antibody Technic,Enzyme Labeled Antibody Technique,Enzyme-Labeled Antibody Technics,Enzyme-Labeled Antibody Techniques,Immunoassays, Enzyme,Immunoenzyme Technic,Immunoenzyme Technique,Immunoperoxidase Technic,Immunoperoxidase Technique,Peroxidase Antiperoxidase Complex Technic,Peroxidase Antiperoxidase Complex Technique,Peroxidase Labeled Antibody Technic,Peroxidase Labeled Antibody Technique,Peroxidase-Antiperoxidase Complex Technics,Peroxidase-Antiperoxidase Complex Techniques,Peroxidase-Labeled Antibody Technics,Peroxidase-Labeled Antibody Techniques,Technic, Enzyme-Labeled Antibody,Technic, Immunoenzyme,Technic, Immunoperoxidase,Technic, Peroxidase-Antiperoxidase Complex,Technic, Peroxidase-Labeled Antibody,Technics, Enzyme-Labeled Antibody,Technics, Immunoenzyme,Technics, Immunoperoxidase,Technics, Peroxidase-Antiperoxidase Complex,Technics, Peroxidase-Labeled Antibody,Technique, Enzyme-Labeled Antibody,Technique, Immunoenzyme,Technique, Immunoperoxidase,Technique, Peroxidase-Antiperoxidase Complex,Technique, Peroxidase-Labeled Antibody,Techniques, Enzyme-Labeled Antibody,Techniques, Immunoenzyme,Techniques, Immunoperoxidase,Techniques, Peroxidase-Antiperoxidase Complex,Techniques, Peroxidase-Labeled Antibody
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D000915 Antibody Affinity A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes. Affinity, Antibody,Antibody Avidity,Avidity, Antibody,Affinities, Antibody,Antibody Affinities,Antibody Avidities,Avidities, Antibody

Related Publications

F Simon, and C Rahimy, and A Krivine, and M Levine, and J M Pepin, and D Lapierre, and E Denamur, and L Vernoux, and A De Crepy, and P Blot
Early diagnosis of vertically acquired HIV-1 infection.
January 1991, AIDS (London, England),
F Simon, and C Rahimy, and A Krivine, and M Levine, and J M Pepin, and D Lapierre, and E Denamur, and L Vernoux, and A De Crepy, and P Blot
[Antibody avidity: use for the diagnosis of HIV early infection].
January 2001, Annales de biologie clinique,
F Simon, and C Rahimy, and A Krivine, and M Levine, and J M Pepin, and D Lapierre, and E Denamur, and L Vernoux, and A De Crepy, and P Blot
Limitations in the laboratory diagnosis of vertically acquired HIV infection.
January 1991, Journal of acquired immune deficiency syndromes,
F Simon, and C Rahimy, and A Krivine, and M Levine, and J M Pepin, and D Lapierre, and E Denamur, and L Vernoux, and A De Crepy, and P Blot
[Serological diagnosis of HIV-1 infection].
July 1994, Revista clinica espanola,
F Simon, and C Rahimy, and A Krivine, and M Levine, and J M Pepin, and D Lapierre, and E Denamur, and L Vernoux, and A De Crepy, and P Blot
Cardiac disease in adolescents with delayed diagnosis of vertically acquired HIV infection.
February 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
F Simon, and C Rahimy, and A Krivine, and M Levine, and J M Pepin, and D Lapierre, and E Denamur, and L Vernoux, and A De Crepy, and P Blot
Pattern of antibody response against the V3 loop in children with vertically acquired immunodeficiency virus type 1 (HIV-1) infection.
March 1993, AIDS research and human retroviruses,
F Simon, and C Rahimy, and A Krivine, and M Levine, and J M Pepin, and D Lapierre, and E Denamur, and L Vernoux, and A De Crepy, and P Blot
A novel antibody avidity methodology for rapid point-of-care serological diagnosis.
June 2010, Journal of virological methods,
F Simon, and C Rahimy, and A Krivine, and M Levine, and J M Pepin, and D Lapierre, and E Denamur, and L Vernoux, and A De Crepy, and P Blot
Chronic lung disease in adolescents with delayed diagnosis of vertically acquired HIV infection.
July 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
F Simon, and C Rahimy, and A Krivine, and M Levine, and J M Pepin, and D Lapierre, and E Denamur, and L Vernoux, and A De Crepy, and P Blot
Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody.
August 1994, Journal of medical virology,
F Simon, and C Rahimy, and A Krivine, and M Levine, and J M Pepin, and D Lapierre, and E Denamur, and L Vernoux, and A De Crepy, and P Blot
Severe airflow obstruction in vertically acquired HIV infection.
December 2014, Respirology case reports,
Copied contents to your clipboard!